Trial Profile
Efficacy of immunotherapy in melanoma patients with brain metastases treated with steroids
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 03 Feb 2020
Price :
$35
*
At a glance
- Drugs Ipilimumab (Primary) ; Nivolumab (Primary) ; Pembrolizumab (Primary)
- Indications Brain metastases; Malignant melanoma
- Focus Therapeutic Use
- Acronyms MEMBRAINS
- 21 Jun 2018 New trial record